Maximum Daily Prednisone Dose Guidelines

Disease-Specific Maximum Doses

The American College of Rheumatology suggests that medium-dose therapy is generally considered 7.5-30 mg/day, with high-dose defined as >30 mg/day, for rheumatic diseases 1
For bullous pemphigoid (severe), the recommended dose is 0.75-1 mg/kg/day, which translates to approximately 50-80 mg/day for an average adult 2
The Kidney International guideline recommends a dose of 60 mg/m² or 2 mg/kg/day with a maximum of 60 mg/day for nephrotic syndrome in pediatric patients 3
The American Journal of Kidney Diseases suggests that in significantly overweight children, dosing should be based on ideal body weight, with consideration of a maximum dose of 80 mg daily 4
For Duchenne muscular dystrophy, the maximum daily dose caps at 30-40 mg/day once the patient reaches approximately 40 kg body weight, as recommended by The Lancet Neurology 5

The Annals of the Rheumatic Diseases guideline states that stress dosing is required for patients on chronic medium/high-dose therapy, with a pragmatic increase in dosage for 3 days or a switch to IV hydrocortisone 1
The same guideline also notes that adrenal suppression risk is anticipated in any patient receiving >7.5 mg daily for >3 weeks 1

The Lancet Neurology recommends a minimum effective daily dose of approximately 0.3 mg/kg/day for conditions like Duchenne muscular dystrophy 5
Praxis Medical Insights suggests that patients on long-term therapy require calcium and vitamin D supplementation with DEXA scanning at 1-2 year intervals 6

Praxis Medical Insights recommends tapering by 1 mg every 4 weeks when reducing the dose below 10 mg to minimize adrenal insufficiency risk 7

The Kidney International guideline suggests an alternate-day dose of 40 mg/m² or 1.5 mg/kg (maximum 40 mg on alternate days) for nephrotic syndrome maintenance 3
The American Journal of Kidney Diseases also recommends an alternate-day dose, with a maximum of 40 mg on alternate days 4

The American College of Rheumatology guidelines suggest that remission definitions in vasculitis use 7.5 mg/day as the maximum acceptable maintenance dose, with adrenal suppression anticipated in any patient receiving >7.5 mg daily for >3 weeks 8

The National Institutes of Health guidelines imply that long-term use at doses <5 mg/day shows acceptable safety profiles with primarily cosmetic side effects, such as bruising and skin-thinning, although doses >10-15 mg/day are associated with significantly increased adverse events 8